International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7858160
Review Article
The Probable Medicinal Usage of Cinnamon in Type 2 Diabetes Mellitus: An Overview
 ,
 ,
 ,
 ,
Published
April 24, 2023
Abstract
Diabetes mellitus (DM) is a chronic disease which causes major public health problemand its estimated that in 2019, worldwide 463 million people were suffering from DM.The main goal for the therapeutics is to regulate the glycemic control and reduce the secondary complications. There are several plant-based products has been reported to have the antidiabetic effect in type 2 diabetes (T2DM). Herein we are discussing the role of cinnamon, an herb with more than 250 species known so far. Each species contains several volatile compounds, which seems to be highly bioactive and helpful in modulating various physiological functions, further improving various disorders. Cinnamon appearing to have mimetic effect of the insulin, reducing insulin resistance via reduction of lipolysis in the adipocytes, improving lipid profile, increases incretin hormones release and regulating the glycemic control. So, we can conclude that due to increased incretins, reduced insulin resistance and insulin mimetic effect, cinnamon helps healthy persons need to secrete less insulin and in T2DM same secreted amount of insulin will help to reduce hyperglycemia due to increased glucose uptake in adipocytes and skeletal muscles. Thus, cinnamon can be used as an adjuvant to the existing therapy for T2DM, which help them to improve their glycemic control and decrease the chances of secondary complications.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1974 Views
67 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved